Amulet Capital Partners, LP

Amulet Capital Partners, LP

Investment Management

Greenwich, Connecticut 1,567 followers

Partnering with exceptional management teams to build industry leaders in healthcare

About us

Amulet Capital Partners is a middle-market private equity investment firm based in Greenwich, CT. Amulet’s investment approach is value-oriented, focusing exclusively on the healthcare sector, in which we have deep industry expertise and strategic relationships across a wide range of verticals. We seek to create significant value by working with strong management teams to build our companies into market leaders in their respective sectors. As such, we invest in a wide variety of transaction structures in both public and private companies. Our flexible investment mandate allows us to consider a wide range of investment opportunities and create customized solutions as appropriate for each investment situation. Amulet Capital Partners' investment team has approximately 40 years of private equity experience and brings together a complementary and unique blend of leveraged buyout, growth capital, and restructuring skills, supplemented by significant expertise across a wide range of healthcare verticals. Collectively, we have invested over $1.5 billion in 13 healthcare transactions over the past 15 years.

Website
http://www.amuletcapital.com
Industry
Investment Management
Company size
11-50 employees
Headquarters
Greenwich, Connecticut
Type
Partnership
Founded
2015
Specialties
Healthcare and Private Equity

Locations

  • Primary

    1 Lafayette Pl

    Suite 301

    Greenwich, Connecticut 06830, US

    Get directions

Employees at Amulet Capital Partners, LP

Updates

  • Amulet Capital Partners, LP reposted this

    View profile for Kathleen Quackenbush, graphic

    Vice President of ESG, Amulet Capital Partners

    Very grateful to the entire Novata team for their support and partnership with Amulet!

    View organization page for Novata, graphic

    27,834 followers

    Amulet Capital Partners, LP, a middle-market private equity firm focused exclusively on the healthcare sector, partnered with Novata to help transform their ESG reporting process into a driver of operational performance and meaningful impact. With Novata, Amulet enhanced efficiency, gained actionable insights, and fostered deeper portfolio engagement. Kathleen Quackenbush, Vice President of ESG at Amulet, shared how the firm is leveraging Novata's platform to build a forward-looking and proactive ESG program: "As we recognize the rising regulatory complexities and stakeholder expectations around this topic, Novata has been a great resource and tool to help us feel more confident amid the evolving landscape." 📖 Read the full case study here: https://lnkd.in/gV9xcghV

    • No alternative text description for this image
  • Congrats to the deal team. Exciting times for Minds and Assembly!

    View organization page for MINDS + ASSEMBLY, graphic

    7,831 followers

    Exciting News! Today, M+A is proud to announce that we’re further scaling our full-range of commercialization services with the acquisition of social media agency HashtagHealth®. HashtagHealth® is the first and only social media agency that focuses exclusively on healthcare brands. They will serve as a division of M+A and will support us in delivering even more value for clients in the media space. Read more on what this exciting acquisition means for the future:

    MINDS + ASSEMBLY acquires premier healthcare social media agency HashtagHealth®

    MINDS + ASSEMBLY acquires premier healthcare social media agency HashtagHealth®

    MINDS + ASSEMBLY on LinkedIn

  • Amulet Capital Partners, LP is pleased to announce the hiring of Michael Keaveney as a Partner and Head of Investor Relations. Mr. Keaveney will oversee the firm’s capital formation, fundraising and investor engagement initiatives, and will work closely with the firm’s leadership team and investment committee to grow the firm’s diversified investor base around the world. “Following the recent close of our oversubscribed third fund, we are pleased to welcome an executive of Michael’s caliber to our team to lead our investor-focused efforts,” said Ramsey Frank, President and Managing Partner at Amulet. “His deep capital raising experience and familiarity with the Amulet platform will significantly benefit our investors as we continue to grow and deliver compelling, thematic-driven investment opportunities within the healthcare landscape.” Read the full press release here: Amulet Capital Appoints Michael Keaveney Head of Investor Relations | Business Wire

  • Amulet Capital Partners announced today it has acquired the Genetics & IVF Institute, Inc., a leading provider of reproductive tissue banking and related reproductive technology services. The transaction includes significant co-investment from a consortium of Amulet Limited Partners. We are excited to partner with GIVF and expand our presence in the fertility space. This is our second platform investment in the fertility space, and we look forward to working closely with the Company to capitalize on its momentum and serve patients across the U.S. and abroad, as well as partner with leading fertility clinics throughout the country. This is our third investment out of Amulet Capital Fund III, following our partnership with minds + assembly, a full-service, design-centric agency and commercialization platform servicing the pharmaceutical, biotech and digital health industries; and Alliance Clinical Network, a leading comprehensive clinical platform serving patients, pharmaceutical sponsors and CROs across numerous clinical areas. You can read the full press release here: https://lnkd.in/ek3GSYFF

    Amulet Capital Partners Acquires Genetics & IVF Institute

    Amulet Capital Partners Acquires Genetics & IVF Institute

    businesswire.com

Similar pages

Funding